Search
InsiderInsights.com

Scopa James Paul (1356950)

Scopa James Paul has been a registered insider at 3 firms since 2009. As a Director at DICE Therapeutics, Inc., Scopa James Paul last made a transaction on 3/17/2023. As a Director at Adverum Biotechnologies, Inc., Scopa James Paul last made a transaction on 11/15/2021. As a Director at Conatus Pharmaceuticals, Scopa James Paul last made a transaction on 7/30/2013.

(DICE)

Titles: DIR

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
1 0% -43% -- -- 1 Year 1 0% -- -- --
1 0% -62% -- -- 9 Month 1 0% -- -- --
1 0% -41% -- -- 6 Month 1 0% -- -- --
1 0% -31% -- -- 3 Month 1 0% -- -- --
1 0% -23% -- -- 1 Month 1 0% -- -- --
1 0% -4% -- -- 1 Week 1 0% -- -- --
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
-- -- -- -- -- 1 Year -- -- -- -- --
-- -- -- -- -- 9 Month -- -- -- -- --
-- -- -- -- -- 6 Month -- -- -- -- --
-- -- -- -- -- 3 Month 1 0% -- -- --
1 0% 24% -- -- 1 Month 1 0% -- -- --
1 0% 11% -- -- 1 Week 1 0% -- -- --
Scorecards Updated 6/13/2023 11:15 PM EST Latest Transaction Date: 3/17/2023
Average days between Transaction and Entered Dates: 3

Avalanche Biotechnologies, Inc. (ADVM, AAVL)

Titles: DIR

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
2 50% 95% 95% 220 1 Year 2 0% -- -- --
2 50% 16% 16% 72 9 Month 2 0% -- -- --
2 50% -0% -0% 31 6 Month 2 0% -- -- --
2 100% 41% 41% 53 3 Month 2 0% -- -- --
2 50% 12% 12% 94 1 Month 2 0% -- -- --
2 0% -6% -6% 0 1 Week 2 0% -- -- --
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
1 100% -67% -- -- 1 Year 1 0% -- -- --
1 100% -37% -- -- 9 Month 1 0% -- -- --
1 100% -61% -- -- 6 Month 1 0% -- -- --
1 100% -33% -- -- 3 Month 1 0% -- -- --
1 100% -17% -- -- 1 Month 1 0% -- -- --
1 100% -5% -- -- 1 Week 1 0% -- -- --
Scorecards Updated 6/13/2023 11:15 PM EST Latest Transaction Date: 11/15/2021
Average days between Transaction and Entered Dates: 1

Conatus Pharmaceuticals Inc. (CNAT, HSTO)

Titles: DIR

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
1 0% -17% -- -- 1 Year 1 0% -- -- --
1 0% -32% -- -- 9 Month 1 0% -- -- --
1 100% 22% -- -- 6 Month 1 0% -- -- --
1 0% -2% -- -- 3 Month 1 0% -- -- --
1 100% 0% -- -- 1 Month 1 0% -- -- --
1 100% 2% -- -- 1 Week 1 0% -- -- --
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
-- -- -- -- -- 1 Year -- -- -- -- --
-- -- -- -- -- 9 Month -- -- -- -- --
-- -- -- -- -- 6 Month -- -- -- -- --
-- -- -- -- -- 3 Month -- -- -- -- --
-- -- -- -- -- 1 Month -- -- -- -- --
-- -- -- -- -- 1 Week -- -- -- -- --
Scorecards Updated 6/13/2023 11:15 PM EST Latest Transaction Date: 7/30/2013
Average days between Transaction and Entered Dates: 2
© 2024 InsiderInsights.com